Previous 10 | Next 10 |
Momenta Pharmaceuticals (NASDAQ: MNTA ) +69% on J&J acquisition . More news on: Momenta Pharmaceuticals, Inc., Hudson Ltd., LightInTheBox Holding Co., Ltd., Stocks on the move, , Read more ...
Unum Therapeutics (NASDAQ: UMRX ) : Q2 GAAP EPS of -$0.24. More news on: Unum Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
CAMBRIDGE, Mass. , Aug. 11, 2020 /PRNewswire/ -- Unum Therapeutics Inc. (Nasdaq: UMRX), a biopharmaceutical company focused on developing novel, best-in-class precision kinase inhibitors for a range of patients living with cancer and other unmet medical needs, today announced fi...
Gainers: INmune Bio (NASDAQ: INMB ) +114% . More news on: INmune Bio, Inc., Perceptron, Inc., Rigel Pharmaceuticals, Inc., Stocks on the move, , Read more ...
WiMi Hologram Cloud (NASDAQ: WIMI ) +85% as holographic AR+AI Vision Drives a New Wave of 5G Applications. More news on: WiMi Hologram Cloud Inc., Kiq Bio LLC, Spartan Energy Acquisition Corp., Stocks on the move, , Read more ...
Nano cap Unum Therapeutics (NASDAQ: UMRX ) jumps 18% premarket on robust volume on the heels of a disclosure from Fairmont Funds Management, LLC of a 19.99% stake consisting of ~6.4M common shares and ~1.3M common shares issuable upon the conversion of Series A non-voting conve...
Kaixin Auto Holdings (NASDAQ: KXIN ) -15% . More news on: Kaixin Auto Holdings, Kiq Bio LLC, Bed Bath & Beyond Inc., Stocks on the move, , Read more ...
Evolus (NASDAQ: EOLS ) -37% on potential barrier to Jeuveau sales in U.S. More news on: Evolus, Inc., Remark Holdings, Inc., Unum Therapeutics Inc., Stocks on the move, , Read more ...
Unum Therapeutics ( UMRX +271.0% ) has completed its acquisition of privately held Kiq , a developer of precision kinase inhibitors, in an all-stock deal. More news on: Unum Therapeutics Inc., Healthcare stocks news, Merger & acquisition news, , Stocks on the move, Read mor...
Are These Penny Stocks On Your List This Month? July has gotten off to a running start for penny stocks and blue-chips alike. Some of the big things in focus right now are coronavirus cases, precious metals prices, and energy. However, beyond that, we’re also seeing attention on thi...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced Andrew Robbins, Chief Executive Officer and President, wil...
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress Cogent Biosciences is focused on the design of rational precision therapies to improve the lives of patients Company on track to advance CGT9486 into ...
SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, Massachusetts Unum’s former chief technology officer Geoff Hodge to join SOTIO to lead BOXR development team and all research and development of the next generation T cell therapies Lead progra...